Loading...
A comparison of a new multinomial stopping rule with stopping rules of fleming and gehan in single arm phase II cancer clinical trials
BACKGROUND: Response rate (RR) alone may be insensitive to drug activity in phase II trials. Early progressive disease (EPD) could improve sensitivity as well as increase stage I stopping rates. This study compares the previously developed dual endpoint stopping rule (DESR), which incorporates both...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3138426/ https://ncbi.nlm.nih.gov/pubmed/21693051 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2288-11-95 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|